AI Read the original on WIRED 2 min read 1

Why 10 Seconds and an AI Throat Snapshot Are Replacing Nasal Swabs

According to WIRED, Japanese healthcare startup Iris has deployed Nodoca, a compact AI-powered optical device across more than 2,000 clinics to diagnose respiratory infections in just over 10 seconds. By capturing high-resolution pharyngeal images instead of relying on uncomfortable nasal swabs, the technology promises to transform routine physical exams for millions of patients. Yet beyond eliminating painful testing, the underlying visual recognition algorithms are quietly paving the way for a far more expansive medical transformation.

#artificial intelligence #medical technology #Japanese startup #AI diagnosis
A medical professional examining a patient's throat using the Nodoca AI optical device.
A medical professional examining a patient's throat using the Nodoca AI optical device. · Image source: WIRED

A 10-Second Optical Scan Replaces the Dreaded Swab

Japanese medical technology firm Iris, founded by former emergency physician Sho Okiyama, has introduced a diagnostic device named Nodoca that analyzes photos of a patient's throat to detect viral illness. Approved under Japan's national health insurance system, the system evaluates pharyngeal mucosal patterns alongside patient symptoms to deliver results in just over 10 seconds.

The device operates by inserting a small, camera-integrated probe into the mouth, capturing subtle micro-visual markers on the pharynx that human eyes cannot easily distinguish during a standard examination.

How Neural Sensing Turns Millions of Throat Photos Into Diagnostic Signals

Unlike conventional medical software that relies solely on symptom questionnaires or laboratory assays, Nodoca combines custom camera hardware with deep-learning computer vision trained on real-world clinical data. Building the underlying visual recognition model required an intensive multi-year data collection effort across Japan:

  • Initial Data Acquisition: Specialized cameras were distributed to approximately 100 medical clinics to gather anonymized pharyngeal imagery over three years.
  • Dataset Scale: The training repository expanded from hundreds of thousands of throat photos at launch to several million verified clinical scans today.
  • Regulatory Validation: Nodoca earned official clearance as a novel medical device for influenza detection before gaining additional approval for COVID-19 identification.

Dr. Okiyama noted that early skepticism centered on data acquisition rather than diagnostic algorithms. «When people hear 'medical AI,' they tend to think of the part that makes diagnoses,» Okiyama explained. «But the real differentiating factor lies in sensing—how the data is acquired.»

Beyond Infectious Disease: The Hidden Biomarkers in the Pharynx

While Nodoca currently saves thousands of patients from painful nasal swabs each day across more than 2,000 medical institutions, its long-term potential reaches far beyond routine flu testing. Because the mucous membranes and vascular structures of the human throat exhibit structural shifts in response to systemic physiological changes, researchers are expanding the algorithm's scope to detect chronic metabolic conditions such as hypertension and diabetes.

Because AI inference costs remain near zero once a model is deployed, adding multiple diagnostic checks to a single photograph adds virtually no financial burden to healthcare providers or patients. Within a decade, a routine ten-second photo of the throat could function as a non-invasive, comprehensive screening tool for systemic health—fundamentally redesigning primary care by catching chronic illness long before physical symptoms appear.

Why it matters

The successful integration of AI diagnostics into national healthcare frameworks marks a decisive shift for the global medical technology market. With Japanese regulator approval enabling coverage for over 2,000 clinics and plans underway for U.S. clinical trials, Iris demonstrates how AI medical devices can achieve commercial scale. For health systems facing physician shortages and rising diagnostic costs, non-invasive optical screening offers a scalable alternative to traditional laboratory assays. As inference costs remain negligible, multi-disease screening via throat imagery could lower preventative care barriers worldwide while setting a benchmark for future AI-driven regulatory approvals in international markets.

FAQ

How does the Nodoca AI system diagnose respiratory infections?
Nodoca uses a compact camera-equipped probe to capture detailed images of a patient's pharynx. Its artificial intelligence algorithm analyzes mucosal and vascular patterns in the throat alongside medical survey data to detect influenza and COVID-19 within 10 seconds without invasive swabs.
Where is the Nodoca AI throat device currently available for patients?
Nodoca is approved under Japan's national health insurance system and is currently deployed in more than 2,000 medical institutions across Japan. The developer, Iris, is also preparing to initiate clinical trials in the United States to expand the system internationally.
What future health conditions could AI throat scans detect?
Researchers at Iris are expanding the deep-learning algorithm to identify subtle changes in pharyngeal mucosa and blood vessels linked to chronic conditions. Future updates aim to detect lifestyle-related diseases such as diabetes and hypertension from a single throat photograph.